Skip to main content
Log in

Impact of Radiation Therapy in Surgically Resected Limited-Stage Small Cell Lung Carcinoma

  • Lung Cancer
  • Published:
Lung Aims and scope Submit manuscript

Abstract

Purpose

To elucidate the role of radiation therapy (RT) in the treatment of surgically resected limited-stage small cell lung carcinoma (LSCLC).

Methods

We queried the SEER database from 1998 to 2012 to identify patients who were diagnosed with LSCLC as their only primary tumor. Kaplan–Meier analysis was utilized to determine disease-specific survival (DSS) and overall survival (OS), while multivariate analysis was used to compare survival in terms of patients and treatment characteristics.

Results

Eight hundred twenty-three LSCLC patients were identified for inclusion within the study. 12-month DSS for patients who did not receive surgery or RT was 31.9% (95% CI 27.7–36.3), 93.3% (95% CI 71.6–90.5) for surgery alone, and 81.0% (95% CI 69.3–88.6) for surgery + RT. 12-month OS was 27.2% (95% CI 23.4–31.1), 74.7% (95% CI 62.6–83.4), and 78.3% (95% CI 66.4–86.4) for no surgery or RT, for surgery alone, and for surgery + RT, respectively. In terms of multivariate analysis, patients receiving surgery alone and patients receiving surgery + RT had a better DSS and OS than those who received neither treatment. However, OS (HR 1.60; 95% CI 0.93–2.75, p = 0.09) and DSS (HR 1.34; 95% CI 0.72–2.51, p = 0.37) were not significantly associated with patients receiving surgery alone compared to surgery + RT.

Conclusions

Surgery alone and surgery + RT were positively associated with DSS and OS compared to patients who did not receive surgery or RT. However, the addition of RT to surgery did not significantly predict DSS or OS compared to surgery alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. American Cancer Society (2015) Cancer Facts & Figures 2015. American Cancer Society, Atlanta

  2. Chute JP et al (1997) Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer Institute. Mayo Clin Proc 72(10):901–912

    Article  CAS  PubMed  Google Scholar 

  3. Micke P et al (2002) Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer—what limits limited disease? Lung Cancer 37(3):271–276

    Article  PubMed  Google Scholar 

  4. Johnson BE et al (2006) Small cell lung cancer clinical practice guidelines in oncology. J Natl Compr Cancer Netw 4(6):602–622

    Article  CAS  Google Scholar 

  5. Ploenes T et al (2012) Surgical treatment of early stage small cell lung cancer. Asian Cardiovasc Thorac Ann 20(6):694–698

    Article  PubMed  Google Scholar 

  6. Clemente M et al (2013) The role of surgery in early stage small cell lung cancer: should it be re-evaluated? Rev Med Suisse 9(407):2170, 2172–2174

  7. Schneider BJ, Saxena A, Downey RJ (2011) Surgery for early-stage small cell lung cancer. J Natl Compr Cancer Netw 9(10):1132–1139

    Article  Google Scholar 

  8. Fox W, Scadding JG (1973) Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up. Lancet 2(7820):63–65

    Article  CAS  PubMed  Google Scholar 

  9. Lad T et al (1994) A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy. Chest 106(6 Suppl): 320s–323s

    Article  CAS  PubMed  Google Scholar 

  10. Takei H et al (2014) Surgery for small cell lung cancer: a retrospective analysis of 243 patients from Japanese Lung Cancer Registry in 2004. J Thorac Oncol 9(8):1140–1145

    Article  PubMed  Google Scholar 

  11. Weksler B et al (2012) Surgical resection should be considered for stage I and II small cell carcinoma of the lung. Ann Thorac Surg 94(3):889–893

    Article  PubMed  Google Scholar 

  12. Stish BJ et al (2015) Long-term outcomes and patterns of failure after surgical resection of small-cell lung cancer. Clin Lung Cancer 16:e67–e73

    Article  PubMed  Google Scholar 

  13. Warde P, Payne D (1992) Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 10(6):890–895

    Article  CAS  PubMed  Google Scholar 

  14. Pignon JP et al (1992) A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 327(23):1618–1624

    Article  CAS  PubMed  Google Scholar 

  15. Perry MC et al (1998) Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: an update of Cancer and Leukemia Group B Study 8083. J Clin Oncol 16(7):2466–2467

    Article  CAS  PubMed  Google Scholar 

  16. Murray N et al (1993) Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 11(2):336–344

    Article  CAS  PubMed  Google Scholar 

  17. Takada M et al (2002) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 20(14):3054–3060

    Article  CAS  PubMed  Google Scholar 

  18. Eskandar A et al (2015) Racial and sex differences in presentation and outcomes of small cell lung cancer in the United States: 1973 to 2010. Chest 147(4):e164–e165

    Article  PubMed  PubMed Central  Google Scholar 

  19. Foster NR et al (2009) Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials. Cancer 115(12):2721–2731

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Sculier JP et al (2008) The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th edition of the TNM classification of malignant tumors and the proposals for the 7th edition. J Thorac Oncol 3(5):457–466

    Article  PubMed  Google Scholar 

Download references

Funding

Dr. Paul Christos was partially supported by the following grant: Clinical and Translational Science Center at Weill Cornell Medical College (UL1-TR000457-06).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bhupesh Parashar.

Ethics declarations

Conflict of interest

None.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

This is a retrospective database study and informed consent was not required for this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, S.K., Manzerova, J., Christos, P. et al. Impact of Radiation Therapy in Surgically Resected Limited-Stage Small Cell Lung Carcinoma. Lung 195, 341–346 (2017). https://doi.org/10.1007/s00408-017-9992-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-017-9992-6

Keywords

Navigation